Cancer-related genes transcriptionally induced by the fungicide Penconazole (cas 66246-88-6)

Add time:07/16/2019    Source:sciencedirect.com

Penconazole is a systemic triazole fungicide mainly used on grapes. The UE Maximum Residue Level (MRL) for penconazole is set at 0.2 ppm in wine and grapes. In the aim of identifying potential biomarkers of exposure to penconazole and possibly highlighting its endocrine disrupting mode of action, we used a transcriptomics-based approach to detect genes, that are transcriptionally modulated by penconazole, by using an appropriate in vitro model. T-47D cells were treated with commercial penconazole or penconazole contaminated grape extracts for 4 h at doses close to the MRL. The whole-genome transcriptomic profile was assessed by using genome 44 K oligo-microarray slides. The list of common genes generated by the two treatments could be representative of potential markers of exposure. In order to understand the role of these genes in key events related to adversity, a pathway analysis was performed on a list of genes with the same modulation trend (up or down). The analysis returned a set of genes involved in Thyroid Cancer Pathway, thus confirming a role of penconazole in endocrine disrupting mediated effects and strongly suggesting a possible mode of action in thyroid carcinogenesis.

We also recommend Trading Suppliers and Manufacturers of Penconazole (cas 66246-88-6). Pls Click Website Link as below: cas 66246-88-6 suppliers

Prev:Long-term occupational and environmental exposure to Penconazole (cas 66246-88-6) and tebuconazole by hair biomonitoring
Next:Simultaneous determination of 4-tert-octylphenol, chlorpyrifos-ethyl and Penconazole (cas 66246-88-6) by GC–MS after sensitive and selective preconcentration with stearic acid coated magnetic nanoparticles)